Clinical Trials Directory

Trials / Completed

CompletedNCT05396664

Adolescent Transition West Africa

Adolescent Transition West Africa: An Outcome Evaluation of a Gender and Sexual and Reproductive Health and Rights Intervention in Mali, Burkina Faso, and Niger

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4,300 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
10 Years – 19 Years
Healthy volunteers
Accepted

Summary

This trial will serve as an outcome evaluation of 'Adolescent Transition in West Africa' (ATWA), a school-based program in Mali, Burkina Faso, and Niger for adolescents ages 10-19. The overall objectives of the project are as follows: Impact: Improved sexual and reproductive health and rights of 472,180 adolescents. Outcome 1: Improved sexual and reproductive health and rights and gender equality knowledge, intent, and behaviors among 472,180 adolescents. Outcome 2: 500 health facilities offer quality adolescent responsive SRH services that are used by adolescent girls and boys. To evaluate program impact, an external evaluation will be conducted. A pre/post cross-sectional evaluation design will be used across two evaluation years.

Conditions

Interventions

TypeNameDescription
BEHAVIORALATWAThe Adolescent Transition in West Africa (ATWA) program is an in-school (Niger, Mali, Burkina Faso) and out-of-school (Niger and Mali) educational intervention implemented by local staff members at Save the Children, local community members, and teachers. ATWA provides internationally-recognized life skills education (LSE) to adolescents ages 10-19 years, and seeks to improve adolescents' knowledge and behaviors regarding sexual and reproductive health and rights. Outcome indicators to assess knowledge, behavior and attitudes of adolescents will vary by adolescent demographics as well as by country context, as based on the final set of curriculum deemed appropriate by the respective Ministries of Education (MOE).

Timeline

Start date
2021-12-01
Primary completion
2023-06-01
Completion
2023-12-01
First posted
2022-05-31
Last updated
2024-09-27

Locations

3 sites across 3 countries: Burkina Faso, Mali, Niger

Source: ClinicalTrials.gov record NCT05396664. Inclusion in this directory is not an endorsement.